Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nonresectable Adrenocortical Carcinoma”

2 trials

Showing 2 of 2 results

Testing effectiveness (Phase 2)WithdrawnNCT00469469
What this trial is testing

Treatment Study Using Bevacizumab for Patients With Adrenocortical Carcinoma

Who this might be right for
Adrenocortical Carcinoma
Dartmouth-Hitchcock Medical Center
Testing effectiveness (Phase 2)Study completedNCT00215202
What this trial is testing

Phase II Trial of ZD1839 (Iressa) in Patients With Nonresectable Adrenocortical Carcinoma (ACC)

Who this might be right for
Nonresectable Adrenocortical Carcinoma
Dartmouth-Hitchcock Medical Center 16

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation